Burkholderia pseudomallei causes a potentially fatal infection called melioidosis. We have developed a nonfluorescent, colorimetric in situ hybridization assay using a specific probe to target 16s rRNA of B. pseudomallei in formalin-fixed, paraffin-embedded infected tissues for diagnostic purposes and to study infectious disease pathology. A 63-base pair DNA probe was synthesized and labeled with digoxigenin by PCR. Probe specificity was confirmed by BLAST analysis and by testing on appropriate microbial controls. The in situ hybridization assay was specifically and consistently positive for B. pseudomallei, showing strongly and crisply stained, single bacillus and bacilli clusters in mainly inflamed tissues in seven human acute melioidosis cases and experimentally infected mouse tissues. Intravascular and extravascular bacilli were detected in both intracellular and extracellular locations in various human organs, including lung, spleen, kidney, liver, bone marrow, and aortic mycotic aneurysm, particularly in the inflamed areas. Intravascular, intracellular bacteria in melioidosis have not been previously reported. Although the identity of infected intravascular leukocytes has to be confirmed, extravascular, intracellular bacilli appear to be found mainly within macrophages and neutrophils. Rarely, large intravascular, extracellular bacillary clusters/emboli could be detected in both human and mouse tissues. B. cepacia and non-Burkholderia pathogens (16 microbial species) all tested negative. Nonpathogenic B. thailandensis showed some cross-hybridization but signals were less intense. This in situ hybridization assay could be usefully adapted for B. pseudomallei identification in other clinical specimens such as pus and sputum.
Burkholderia pseudomallei is a motile, Gram-negative, non-spore-forming soil bacterium that is readily recovered from water and wet soils in endemic areas of Southeast Asia and Northern Australia. 1 It causes melioidosis, an infectious disease of major public health importance. B. pseudomallei is responsible for 20% of community-acquired septicemia and 40% of sepsis-related deaths in Northern Thailand, 2 whereas in northern Australia, it accounts for 6% of all bacteremias and 32% of community-acquired bacteremic pneumonia. 3 In Malaysia, hundreds of cases have been reported in the past decade. 4 B. pseudomallei has demonstrated high antibiotic resistance 5 and has been classified as a category B potential bioterrorism agent by the United States Centers for Disease Control and Prevention.
It is believed that melioidosis is greatly underdiagnosed, and the true incidence and epidemiology of the disease in endemic areas remains unknown. 4 This is partly because melioidosis, often described as a great mimicker, has protean clinical manifestations, including aortic aneurysm. 6, 7 Needless to say in infectious diseases, identification of the causative agent and its timeliness is of paramount importance in determining treatment outcome and prognosis. Traditional laboratory diagnosis of melioidosis using the gold standard bacterial culture requires prolonged incubation and laborious biochemical methods such as the API 20NE for confirmation. Molecular techniques using conventional, multiplex, or real-time PCR [8] [9] [10] and DNA microarrays 11 have greatly improved the speed of diagnosis. However, these newer methods may suffer from easy contamination leading to false positive results.
The in situ hybridization technique, a molecular assay that uses labeled probes to hybridize with nucleotide targets, can be readily adapted for the detection and identification of microorganisms. We believe the ability to visualize bacilli with this technique could reduce the likelihood of false positive results inherent in other molecular assays. In situ hybridization has been successfully applied to detect various bacteria, including Helicobacter pylori, 12 Haemophilus influenza, 13 and Klebsiella pneumoniae. 14 Recently, Hagen et al 15 reported a fluorescence in situ hybridization technique using a set of oligonucleotide probes for the identification of B. pseudomallei, B. mallei, and B. thailandensis in bacterial cell smears and experimentally infected mouse tissues. Although the oligonucleotide probes were not specific to B. pseudomallei, they were able to differentiate B. pseudomallei, B. mallei, and B. thailandensis using a multiple-probe exclusion approach.
We have developed a larger DNA probe that targets the 16s rRNA of B. pseudomallei for its identification in an in situ hybridization assay that uses a nonfluorescent, colorimetric detection method. The purpose is to improve the diagnosis of melioidosis and to develop a research tool to study the pathology and pathogenesis in infected tissues from human cases as well as animal models. As the clinical diagnosis of melioidosis is often not suspected initially, optimal fresh specimens for bacterial culture and molecular investigations are often not sent at the time of biopsy for histopathological examination. As the in situ hybridization technique can be done on standard formalin-fixed, paraffin-embedded tissues, it can be readily adapted for routine pathological diagnosis. In contrast to fluorescence in situ hybridization, a nonfluorescent, colorimetric in situ hybridization has the advantage of facilitating light microscopic assessment of the surrounding tissues in which the bacilli are found without the problems of poor background details and autofluorescence as previously reported. 15 Herein, we report the demonstration of whole bacilli in infected human and mouse tissues using this technique that is potentially useful for diagnosis and to further understand the spread and pathogenesis of B. pseudomallei in the host.
Materials and methods

Preparation of Probe Targeting 16s rRNA
The rRNA sequences of B. pseudomallei (strain K96243, reference number: S000406475) and various other bacteria were downloaded from the RNA database project website (http://rdp.cme.msu.edu/). By aligning and comparing these sequences, we identified a 63-nucleotide region between nucleotides 955 and 1017 that appeared to be sufficiently specific and unique for B. pseudomallei for probe hybridization. This region had o50% sequence similarity to non-Burkholderia bacteria but shared 88.9% and 90.5% similarity to B. cepacia and B. thailandensis, respectively.
A forward primer 5 0 -ACCCTTGACATGGTCGG AAG-3 0 and a reverse primer 5 0 -CTGTGCGCCG GTTCTCTT-3 0 that flank this region were designed and synthesized for PCR use. These primers were checked by a BLAST analysis to confirm their specificity. A digoxigenin-labeled DNA probe (Patent pending: PI 2012700008) was made from the reverse-transcriptase PCR (RT-PCR) product of this region. Briefly, RNA was extracted from a pure colony of B. pseudomallei using TRIzol reagent (InvitroGen, USA). The RT-PCR was performed using the AMV RT-PCR kit (Promega, USA) with the reverse primer and RNA template to obtain cDNA. The PCR step uses the cDNA template and the HotStarTaq DNA Polymerase kit (QIAGEN, USA) performed in the Veriti 96 Wells Thermal Cycler (Applied Biosystems, USA) using a protocol of 95 1C for 10 min, 35 cycles at 94 1C for 1 min, 56 1C for 45 s, 72 1C for 45 s, and finally 72 1C for 10 min. The products were purified using the QIAGEN Gel Purification kit (QIAGEN), sequence-confirmed (FirstBase, Malaysia) and cloned using the pGEM-T Easy Vector system (Promega, USA). Finally, a second PCR that incorporates digoxigenin-11-dUTP (Roche, Germany) 16 was done using the cloned RT-PCR products as template and the same PCR protocol to produce the probe.
In Situ Hybridization Protocol
The in situ hybridization was performed as described by Ong et al 17 with some modifications. Briefly, bacterial smears and deparaffinized, rehydrated 3 mm tissue sections were pretreated sequentially with 0.2N HCl (20 min, room temperature), Proteinase-K (100 mg, 20 min, 37 1C), and lysozyme (1 mg/ml, 30 min, room temperature). The sections were then incubated overnight at 42 1C in standard hybridization buffer together with B1 ng/ml of probes. After the washing and blocking steps, anti-digoxigenin antibody (Roche) conjugated with alkaline phosphatase was added followed by the Liquid Permanent Red (Dako, USA) as substrate. The tissues were counterstained with Mayer's hematoxylin and mounted with Faramount (Dako) and systematically viewed under a light microscope.
In Situ Hybridization Controls
Three Burkholderia species, B. pseudomallei (two strains: K96243 and CMS), B. cepacia, and B. thailandensis, and 16 non-Burkholderia microorganisms were used as controls to test the specificity of the probe (Table 1 ). B. mallei was not included in the controls as the isolate was not available. All the microorganisms were grown overnight in LB broth, washed, formalin fixed, and resuspended in phosphate-buffered saline (PBS) before spreading onto silane-coated glass slides as bacteria cell smears. The smears were heat-fixed for 5 min before use. To prepare formalin-fixed, paraffin-embedded sections of the same bacteria cells, fresh, normal mouse liver and lung tissues were first incubated together with the bacteria in LB broth for 2.5 h, and then washed, formalin fixed, and routinely processed into paraffin blocks. The mouse tissues provided scaffolds for bacteria adhesion and penetration to minimize bacterial cell loss during tissue processing. Formalin-fixed, paraffin-embedded human tissues known to be infected by Mycobacterium tuberculosis, Actinomyces spp., and Helicobacter pylori were also used as additional negative controls.
Human Melioidosis Cases
A total of seven human autopsy cases of acute melioidosis were studied ( Table 2 ). Four were collected from 1978 to 1996 and archived in the Department of Pathology, Faculty of Medicine, University of Malaya. Three cases were referred from Hospital Queen Elizabeth, Sabah, Malaysia, for diagnostic purposes. Ethical clearance was obtained from the Ethics Committee of the University of Malaya Medical Center. All available tissue samples were tested and all cases (Table 2) were culture proven as melioidosis. Tissue sections (3 mm thick) from all available paraffin blocks were stained with hematoxylin and eosin and Brown-Hopps Gram stains as previously described, 18 and examined under a light microscope.
Experimentally Infected Mouse Tissues
Healthy Balb/c mice (n ¼ 15) (obtained from Monash University Sunway Campus, Malaysia) were infected with B10 7 CFU/ml of B. pseudomallei via the intraperitoneal (IP) route. Mock-infected mice (n ¼ 3) were injected with PBS buffer. The mice were kept in an individual ventilated cage system (ITS, Italy) and observed daily. Tissues from dead mice were harvested, formalin fixed, and routinely processed to prepare paraffin blocks including 15 blocks each of spleen, lung, and liver, and 3 blocks each of stomach and kidney. All the tissues were cut into 3 mm thick sections and placed onto silanecoated glass slides for in situ hybridization. All the work involving bacteria and infected animals was done inside a Level II biosafety cabinet, and in accordance with the ethics code set by the Animal House, University of Malaya.
Results
Probe Specificity
The probe specificity test results on B. pseudomallei, B. cepacia, and B. thailandensis and 16 nonBurkholderia microorganisms are shown in Table 1 . B. pseudomallei and B. thailandensis were both in situ hybridization positive in control bacterial smears and formalin-fixed, paraffin-embedded sections, but the signal intensities for B. pseudomallei were relatively stronger compared with B. thailandensis. B. pseudomallei was crisply and strongly stained red as single whole bacillus or bacilli clusters (Figure 1a ). All other microorganisms, including B. cepacia, gave negative results (Figure 1b) . The areas of in situ hybridization positivity generally corresponded very well with the areas in which Gram-negative bacilli were stained by the Brown-Hopps method.
In Situ Hybridization on Infected Human Tissues
Tissues from at least one organ tested positive in all the seven human cases studied and positive staining results were mainly associated with inflammatory lesions ( Table 2 ). The lung was the most likely organ to be positive (cases [1] [2] [3] [4] [5] [6] . Bacilli were demonstrated in alveolar walls either within capillaries or intracellularly (Figure 2b) . In more severe lung parenchymal inflammatory lesions, individual or clusters/chains of bacilli were often numerous (Figure 2a) . Within blood vessels in the lungs and other organs, individual 'free-floating' bacillus or intracellular bacilli were observed (Figure 2d) . Rarely, large 'free-floating' bacillary clusters or emboli measuring nearly 20 mm in diameter could be found (Figure 2c ). Bacilli could be detected in kidney glomeruli, possibly within capillaries (Figure 2e ), in bone marrow (Figure 2f) , and in the wall of the aortic mycotic aneurysm (Table 2 , case 7). Intracellular bacteria were found in cells that morphologically resemble macrophages and neutrophils.
In Situ Hybridization on Infected Mouse Tissues
Overall, bacteria found in tissues from mice with acute melioidosis (all mice died within 3 days after infection) showed very crisp and strong positivity. Individual and small clusters of bacilli in mycotic aneurysm of abdominal aorta.
a Cases 1-3 were previously described by Wong et al. 19 Modern Pathology (2014) 27, 657-664
B. pseudomallei in situ hybridization
Infection was most severe in the spleen (Figure 1c ) and liver (Figure 1f ) where large clusters of bacilli with or without surrounding inflammation were observed. Individual intracellular or extracellular bacilli were also well demonstrated. Compared with the spleen and liver, bacilli in the lungs were sparse, 
Discussion
The in situ hybridization assay to detect B. pseudomallei is useful and sensitive enough to stain whole bacilli to facilitate localization and identification in infected tissues. As expected, in the human autopsy tissues, both intra-and extracellular bacteria were detected in the organs commonly reported to be involved, such as lung, spleen, liver, and kidney. 19, 20 In the lung and other organs, bacilli were detected in or around parenchymal inflammatory lesions, and occasionally also in alveolar walls and other tissues that were not obviously inflamed. Within some blood vessels, intracellular intact single bacillus (Figure 2d ) and 'free-floating' extracellular single bacillus or small bacillary clusters could be unequivocally identified.
Although it is well known that B. pseudomallei is able to survive and proliferate intracellularly, 21 we believe this is the first time that bacteria have been demonstrated within circulating leukocytes in vivo. The overall morphological appearance of intact bacilli suggests that the bacteria were viable but further studies are needed to confirm this, and to identity which type of leukocyte could be infected intravascularly. It is possible that the intravascular, intracellular location could contribute to survival by helping bacteria evade the host immune response. Moreover, appropriate antibiotics may be less effective against intracellular bacteria. 21 The rare, large bacillary cluster or embolus in B. pseudomallei septicemia bear some resemblance to the septic emboli described in hamsters experimentally infected with B. mallei. 22 We speculate that bacillary emboli (Figure 2c ) or smaller clusters may be held together and protected against antibiotics and host immune response by a surrounding biofilm, a well-known phenomenon in B. pseudomallei infection. 23 Bone marrow infection, shown in one of our cases (case 5, Table 2 ), is consistent with bone marrow inflammation found in another series, 24, 25 and the observation that bacteria could be cultured from bone marrow. 26 Morphologically intact bacteria were demonstrated in the wall of the mycotic aneurysm confirming B pseudomallei infection (case 7, Table 2 ). Although generally mycotic aneurysm is rare in melioidosis, 6 it has been reported that B. pseudomallei is the most common etiology of mycotic aneurysm in Thailand. 7 The histology findings in the acute melioidosis mouse model appear to parallel the observations in the human tissues, although the mouse model was infected by the IP route whereas humans are usually infected via inhalation or skin inoculation. In particular, we were able to confirm intravascular, intracellular localization of bacteria in the mouse model (Figure 1e) . Generally, bacilli stained more crisply, most likely because mouse tissues were formalin fixed immediately, whereas there is invariably some autolysis in human tissues because of autopsy delays. It may be possible to use in situ hybridization combined with other studies, for example ultrastructural studies, to investigate whether intravascular, infected leukocytes may act as 'trojan horses' to penetrate vascular walls to cause parenchymal inflammation in the mouse model. As bacterial spread in lymphatics is unknown, 27 our in situ hybridization technique could also be used to study this.
As the probes target 16s rRNA sequences, in addition to genomic DNA, theoretically it should be able to hybridize with the rRNA found in the thousands of free or membrane-bound ribosomes within a single bacteria cell. In practice, this strategy worked as single whole bacillus could be intensely and crisply stained. Our nonfluorescent colorimetric in situ hybridization assay has the advantage of allowing for direct visualization of bacilli and assessment of reactive changes in surrounding tissues. Our probe did not hybridize with the nonBurkholderia microorganisms and B. cepacia but cross-hybridized with B. thailandensis, although to a lesser extent. This is most likely because B. pseudomallei and B. thailandensis shared 490% homology in the targeted rRNA region. Fortunately, B. thailandensis is an avirulent, nonpathogenic Burkholderia species 28, 29 and is an extremely rare infection in humans and animals, hence unlikely to be encountered in clinical materials/tissues. Higher stringency washes in the posthybridization step of the in situ hybridization procedure to minimize cross-hybridization were unsuccessful. A further drawback is that our in situ hybridization assay was not tested on B. mallei, although we predict our probe should cross-hybridize with B. mallei as the nucleotide homology in the targeted region is 100%. Fortunately, like B. thailandensis, human B. mallei infection is rare compared with B. pseudomallei infections in endemic areas. Confirmation of B. pseudomallei infection in infected tissues can be done by performing a PCR on nucleic acid extracted from formalin-fixed, paraffin-embedded tissues. 10 Using immunohistochemistry to detect B. pseudomallei is possible but it is very difficult to visualize individually stained bacteria, 20 and there is often a high background of positively stained bacterial debris. The in situ hybridization assay is far better to visualize intact bacilli and there is relatively little background staining. We believe this is essential for diagnostic confidence.
We speculate that this method could be applied directly on smears for bacterial identification using bodily fluids or pus as was demonstrated for M. tuberculosis 30 in sputum and Legionella spp. in bronchioalveolar lavages. 31 Further tests and more extensive studies should be carried out to validate the usefulness of the probe for various clinical diagnostic purposes.
